CECR2 gene inhibition prevents triple-negative breast cancer from metastasizing, stud

[News]

A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing.

More... (https://www.news-medical.net/news/20220202/CECR2-gene-inhibition-prevents-triple-negative-breast-cancer-from-metastasizing-study-shows.aspx)